JCM
VRTX icon

J2 Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

J2 Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-928
Closed -$413K – 133
2025
Q2 		$413K Buy
928
+250
+37% +$115K 0.33% 80
2025
Q1 		$329K Buy
678
+7
+1% +$3.26K 0.3% 74
2024
Q4 		$270K Buy
+671
New +$311K 0.25% 96
2023
Q3 		$422K Buy
1,213
+3
+0.2% +$1.05K 0.53% 48
2023
Q2 		$426K Buy
1,210
+34
+3% +$11.5K 0.51% 51
2023
Q1 		$371K Buy
+1,176
New +$353K 0.57% 46
2022
Q3 		– Sell
-903
Closed -$254K – 103
2022
Q2 		$254K Sell
903
-1,012
-53% -$271K 0.39% 64
2022
Q1 		$500K Buy
1,915
+41
+2% +$9.73K 0.55% 31
2021
Q4 		$412K Buy
+1,874
New +$364K 0.39% 43

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return